Allergy Therapeutics plc
AGYTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $22 | $13 | $14 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $11 | $9 | $7 | $10 |
| Inventory | $19 | $12 | $13 | $12 |
| Other Curr. Assets | -$13 | $0 | $1 | $0 |
| Total Curr. Assets | $35 | $42 | $33 | $35 |
| Property Plant & Equip (Net) | $24 | $23 | $24 | $23 |
| Goodwill | $5 | $3 | $3 | $3 |
| Intangibles | $1 | $1 | $1 | $2 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $2 | $0 | $0 | $0 |
| Other NC Assets | $1 | $3 | $3 | $5 |
| Total NC Assets | $33 | $31 | $31 | $34 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $68 | $73 | $65 | $69 |
| Liabilities | – | – | – | – |
| Payables | $4 | $14 | $4 | $20 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $1 | $0 | $5 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $30 | $10 | $10 | $3 |
| Total Curr. Liab. | $37 | $26 | $21 | $25 |
| LT Debt | $58 | $43 | $29 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $10 | $11 | $11 | $9 |
| Total NC Liab. | $69 | $54 | $41 | $17 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $7 | $8 | $8 |
| Total Liabilities | $131 | $80 | $61 | $43 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $5 | $5 | $5 |
| Retained Earnings | -$268 | -$210 | -$199 | -$175 |
| AOCI | $7 | $44 | $43 | $42 |
| Other Equity | $215 | $155 | $155 | $155 |
| Total Equity | -$39 | -$7 | $4 | $26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $93 | $73 | $65 | $69 |
| Net Debt | $43 | $23 | $18 | -$4 |